文献速递关节外科创伤骨科

同种异体骨植骨与抗内突笼治疗巨大髋臼骨缺损的生存分析

Survival Analysis of Allografting and Antiprotrusio Cage in Treating Massive Acetabular Bone Defects.
PubMed 文献 · J Arthroplasty · 2020-08-28

该研究回顾性分析了2002年至2017年间在本机构使用抗内突笼治疗巨大髋臼骨缺损(Paprosky IIc、III型及骨盆不连续)的84例病例,平均随访6.2年,生存率为82.1%。骨盆不连续、单独使用颗粒状同种异体骨重建以及宿主骨固定点少于4个与更高的失败率相关(风险比分别为4.02、3.42和9.9)。作者认为抗内突笼联合支撑性同种异体骨植骨并牢固固定于宿主骨(超过4个固定点)有利于处理巨大髋臼骨缺损,但骨盆不连续仍是挑战,需要进一步研究三翼植入物、杯笼和3D打印植入物等技术或假体创新。

要点

  • 84例抗内突笼治疗巨大髋臼骨缺损的平均随访6.2年生存率为82.1%。
  • 骨盆不连续、单独颗粒骨植骨及固定点少于4个与更高失败率相关(HR 4.02、3.42、9.9)。
  • 抗内突笼联合支撑性同种异体骨植骨并牢固固定(超过4个固定点)有益。

核心结论

  • 抗内突笼联合支撑性同种异体骨植骨并牢固固定于宿主骨(超过4个固定点)有利于处理巨大髋臼骨缺损。
  • 骨盆不连续仍是挑战,需要进一步研究三翼植入物、杯笼和3D打印植入物等技术或假体创新。

研究设计与样本

  • 回顾性分析2002年至2017年间作者所在机构使用抗内突笼治疗巨大髋臼骨缺损(Paprosky IIc、III型及骨盆不连续)的所有病例,共84个抗内突笼、77例患者,平均年龄62.9岁,平均随访6.2年。

主要发现

  • 84个抗内突笼的生存率为82.1%。
  • 15髋出现失败,包括机械性失败8髋、复发性脱位1髋、髋关节功能差1髋和假体周围关节感染5髋。
  • 骨盆不连续与更高失败率相关(风险比4.02)。
  • 单独使用颗粒状同种异体骨重建与更高失败率相关(风险比3.42)。
  • 宿主骨固定点少于4个与更高失败率相关(风险比9.9)。

关键数值与推荐

  • 失败定义为笼松动或断裂、髋关节功能差或任何原因的笼翻修。

临床怎么用

  • 作者认为抗内突笼联合支撑性同种异体骨植骨并牢固固定于宿主骨(超过4个固定点)有利于处理巨大髋臼骨缺损。
  • 作者指出骨盆不连续仍是挑战,需要进一步研究三翼植入物、杯笼和3D打印植入物等技术或假体创新。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Massive acetabular bone defects reconstructed with allografting and antiprotrusio cage in revision hip arthroplasty is less reported in the literature. We here report a series of 84 antiprotrusio cages and analyze the risk factors associated with failure. METHODS: All instances of use of an antiprotrusio cage for massive acetabular defect (Paprosky type IIc, III, and pelvic discontinuity) between 2002 and 2017 in the authors' institute were reviewed after institutional review board's approval. Survival analyses based on clinical data, bone defect (Paprosky system), type of allograft, size of cage, fixation quality, and position of cage were performed. Failure was defined as cage loosening or breakage, poor hip function, or cage revision for any reason. RESULTS: A total of 84 cages in 77 patients (mean age, 62.9 years), with a mean follow-up period of 6.2 years, had a survival rate of 82.1%. Failure was noted in 15 hips, including mechanical failure in 8 hips, recurrent dislocation in 1 hip, poor hip function in 1 hip, and periprosthetic joint infection in 5 hips. Pelvic discontinuity, reconstruction with morselized allograft alone, and fewer than 4 fixation points to the host bone were associated with higher failure rates (hazard ratios, 4.02, 3.42, and 9.9, respectively). CONCLUSION: We found that an antiprotrusio cage combined with strut allografts, fixed securely to the host bone (>4 fixation points), are beneficial for the management of massive acetabular bone defects. However, pelvic discontinuity remains a challenge that warrants the further study of technical or prosthetic innovations, such as triflange implants, cup cage, and 3D-printed implants.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Chang CY, Wu CT, Numan H, et al. Survival Analysis of Allografting and Antiprotrusio Cage in Treating Massive Acetabular Bone Defects. J Arthroplasty. 2020. PMID: 32943318. doi:10.1016/j.arth.2020.08.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。